Search

everythinglearnresearchcommunity

for

Search:↓

The Polish version of the Alopecia Areata Quality of Life Index is a reliable tool for assessing quality of life in Polish-speaking patients with alopecia areata.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

Hair loss is more common in men aged 18-49 and increases with age.

Most women with PCOS use positive coping strategies, but some with more psychological stress use negative ones.

Use antiandrogens and other treatments for hair loss.

Homeopathy improved hair loss and well-being in a woman with chronic hair loss.

An 8-year-old boy with hair loss had hair regrowth and responded well to clobetasol propionate treatment.

The electronic version of the Dermatology Life Quality Index is as effective as the paper version, with most patients preferring it.

Therapeutic intervention improved the quality of life for Japanese lupus patients with skin issues.

Androgenetic alopecia significantly harms quality of life, affecting emotions and relationships.

Keloids significantly reduce quality of life, and treating symptoms should be prioritized.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Some medicinal plants can help heal wounds and may lead to new treatments.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Oral spironolactone's effectiveness for adult female acne is not well-supported by strong evidence.

Baricitinib is effective and safe for treating severe alopecia areata.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

Alopecia significantly lowers women's quality of life, with psychological and social challenges, highlighting the importance of early treatment and support.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

People with hair loss conditions experience more anxiety, depression, and a lower quality of life than those without these conditions.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Many recovered COVID-19 patients in Saudi Arabia still experience symptoms like fatigue and anxiety, especially older adults and those with other health issues.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Eyelashes protect the eyes, but more research is needed to understand how.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.